Lv1
10 积分 2024-04-27 加入
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: a single-arm, phase 2 trial
9天前
已完结
First-Line Tyrosine Kinase Inhibitors in Soft-Tissue Sarcomas: A Role for Anlotinib?
12天前
已完结
Rational combination of cancer therapies with PD1 axis blockade
17天前
已完结
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
17天前
已完结
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
19天前
已完结
Perioperative immunotherapy in soft tissue sarcomas
19天前
已完结
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
20天前
已完结
Lung cancer treatment: 20 years of progress
25天前
已完结
Lactylation increases the stability of RBM15 to drives m6A modification in non‐small‐cell lung cancer cells
26天前
已完结
Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials
27天前
已完结
皖公网安备34019202002308
